Advance Search
You have access

Celiac Disease and Schizophrenia

Cite this:
Richard P Conti, J. M. A. (2016). Celiac Disease and Schizophrenia. Journal of Medical Biomedical and Applied Sciences, 3. https://doi.org/10.15520/.v3i0.12
Copyright @ 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
336
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS

Abstract

The relationship between schizophrenia and celiac disease (CD) has been reported in the research literature for over 70 years. CD is a T-cell mediated autoimmune inflammatory disease of the small intestine and is activated by the consumption of prolamins found in wheat, rye, oats or barley in genetically predisposed individuals. Incidence and prevalence rates for CD in the United States (US) are widespread, affecting 1% of the aggregate population in not at-risk groups, or1 out of 133 persons. Gluten, the trigger for CD and cause for damage to the lining of the small intestine, has been demonstrated to impair the nervous system. Neurologic disorders including ataxia, epilepsy and headache have been well documented in the literature. Psychiatric conditions including depression, anxiety and schizophrenia have also been studied with great interest among adults and children with CD. Additionally, impaired cognitive function has also been reported in individuals with CD and schizophrenia. Past and current studies on schizophrenia have demonstrated a reduction in psychotic symptoms following adherence to a gluten-free diet, however studies with smaller sample sizes showed no significant differences. Recommendations for future empirical research to further investigate the relationship between schizophrenia, cognitive function and CD are discussed.
KEYWORDS:

 Additional Information

Downloads

Download data is not yet available.

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

References

  1. A. Lerner, T. Matthias, Celiac disease: Intestinal, heart and skin interconnections Int J Celiac Dis.3 (2015) 28-30.
  2. G.F. Chico, M.A. Chico, Demystifying celiac disease, Patient Care. 39 (2005)16-20.
  3. A. Fasano, I. Berti, T. Gerarduzzi, T. Not, R.B. Colletti, S. Drago, K. Horvath, Prevalence of celiac disease in at-risk and not-at-risk groups in the United States, Arch Intern Med.163 (2003). 286-292.
  4. A. Fasano, Surprises from celiac disease, Sci Am. 301 (2009) 54-61.
  5. Harvard Women’s Health Watch. (2006). Celiac disease: When the body goes against the grain. Retrieved from www.health.harvard.edu
  6. A. Fasano, Celiac disease: How to handle a clinical chameleon, N Engl JMed.348 (2003) 2568-2570.
  7. R.P. Anderson, M.J. Henry, R. Taylor, E.L. Duncan, P. Danoy, M.J. Costa, J.A. Pasco, A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways, BMC Med.11(2013) 188.
  8. M. Edwards, Coeliac disease—an update, PractNurs.31 (2006) 1-6.
  9. A. Lerner, Factors affecting the clinical presentation and time diagnosis of celiac disease: The Jerusalem and the West Bank-Gaza experience. Israel J Med Sci.11 (1994) 294-295.
  10. A. Lerner, N. Agmon-Levin, Y. Shapira, B. Gilburd, S. Reuter, I. Lavi, Y. Schoenfeld, The thrombophilic network of autoantibodies in celiac disease, BMC Med.11(2013) 89.
  11. A. Lerner, B.F. Makhoul, R. Eliakim, Neurological manifestations of celiac disease in children and adults, Eur Neurol. 4 (2012) 15-20.
  12. G. Addolorato, A. Mirijello, C. D’Angelo, L. Leggio, A. Ferrulli, L. Vonghia, G.Gasbarrini, Social phobia in coeliac disease, Scand J Gastroenterol.43 (2008)410-415.
  13. W.T. Hu, J.A. Murray, M.C. Greenaway, J.E. Parisi, K.A. Josephs, Cognitive impairment and celiac disease, Arch Neurol.63(2006) 1440-1446.
  14. I.T. Lichtwark, E.D. Newnham, S.R. Robinson, Cognitive impairment in coeliac disease improves on a gluten-free diet and correlates with histological and serological indices of disease severity, Aliment PharmacolTher.40(2014) 160-70.
  15. G. Wagner, G. Berger, U. Sinnreich, V. Grylli, E. Schober, W.D. Huber, A. Karwautz, Quality of life in adolescents with treated celiac disease: Influence of compliance and age at diagnosis, J PediatrGastroenterolNutr. 47 (2005) 555-561.
  16. R.J. Presutti, J.R. Cangemi, H.D. Cassidy, D.A. Hill, Celiac disease,AmFamPhysician. 76(2007) 1795-1802.
  17. J.A. Arnone, R.P. Conti, Neuropsychiatric features of celiac disease, Int J Celiac Dis.3(2015) 77-83.
  18. R.P.K. Ford, The gluten syndrome: A neurological disease, Med Hypotheses.73 (2009) 438-440.
  19. J.R. Jackson, W.W. Eaton, N.G. Cascella, A. Fasano, D.L. Kelly, Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity, Psychiatr Q.83 (2012) 91-102.
  20. N. Zelnik, A. Pacht, R. Obeid, A. Lerner, Range of neurologic disorders in patients with celiac disease, Pediatr.113(2004) 1672-1676.
  21. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, fifth ed., Washington, DC, 2013.
  22. P. Fusar-Poli, G. Deste, R. Smieskova, S. Barlati, A.R. Yung, O. Howes, R.D. Stieglitz, A. Vita, P. McGuire, P., S. Borgwardt, Cognitive functioning in prodromal psychosis: A meta-analysis. Arch Gen Psychiatry.69 (2012) 562-571.
  23. A.E. Kalaydjian, W. Eaton, N. Cascella, A. Fasano, The gluten connection: The association between schizophrenia and celiac disease, Acta Psychiatrica Scandinavica. 113 (2006) 82-90.
  24. F. C. Dohan, Wartime changes in hospital admissions for schizophrenia: A comparison of admission for schizophrenia and other psychoses in six countries during World War II, Acta Psychiatrica Scandinavica. 42 (1966) 1-23.
  25. F.C. Dohan, Wheat consumption and hospital admissions for schizophrenia during World War II. A preliminary report, Am J ClinNutr.18 (1966) 7-10.
  26. F.C. Dohan, J.C. Grasberger, F.M. Lowell, H.T. Johnston, A.W. Arbegast, Relapsed schizophrenics: More rapid improvement on a milk- and cereal-free diet, Brit J Psychiatry. 115 (1969) 595-596.
  27. F.C. Dohan, J.C. Grasberger, Relapsed schizophrenics: Earlier discharge from the hospital after cereal-free, milk-free diet, Am J Psychiatry. 130(1973) 685-688.
  28. F.C. Dohan, E.H. Harper, M.H. Clark, R.B. Rodriguez, V. Zigas, Is schizophrenia rare if grain is rare? Biol Psychiatry. 19 (1984) 383-399.
  29. J.R. Jackson, W.W. Eaton, N.G. Cascella, A. Fasano, D.L. Kelly, Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity, Psychiatric Q. 83 (2012) 91-102.
  30. N.G. Cascella, D. Kryszak, B. Bhatti, P. Gregory, D.L. Kelly, J.P. McEvoy, Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population, SchizophrBull. 37 (2011) 94-100.
  31. S.Z. Jin, N. Wu, Q. Xu, X. Zhang, G.Z. Ju, M.H. Law, J. Wei, A study of circulating gliadin antibodies in schizophrenia among a Chinese population,Schizophr Bull. 38(2012) 514-518.
  32. K. L. Reichelt, J. Landmark, Specific IgA antibody increases in schizophrenia, BiolPsychiatry. 37 (1995) 410-413.
  33. F. Dickerson, C. Stallings, A. Origoni, C. Vaughan, C., Khushalani, S. Leister, F., Yang, S., Krivogorsky, B., Alaedini, A., and Yolken, R., Markers of gluten sensitivity and celiacdisease in recent-onset psychosis and multi-episode schizophrenia,Biol Psychiatry. 68 (2010) 100-104.
  34. S.J. Chen, Y.L. Chao, C.Y. Chen, C.M. Chang, E. Wu, W. Chia-Hsuan, H.J. Tsai, Prevalence of autoimmune diseases in in-patients with schizophrenia: Nationwide population-based study, Brit J Psychiatry. 200 (2012) 374-380.
  35. J. Jackson, W. Eaton, N. Cascella, A. Fasano, D. Santora, K. Sullivan, S. Feldman, H.Raley, R.P. McMahon, W.T. Carpenter, H. Demyanovich, D.L. Kelly, Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia, Schizophr Res. 159 (2014) 539-542.
  36. R. Peleg, Z.I. Ben-Zion, A. Peleg, L. Gheber, M. Kotler, Z. Weizman, A. Shiber, A. Fich, Y. Horowitz, P. Shvartzman, P., Bread madness' revisited: Screening for specific celiac antibodies among schizophrenia patients, EurPsychiatry. 19(2004) 311-314.
  37. D. Samaroo, F. Dickerson, D.D. Kasarda, P.H.R. Green, C. Briani, R.H. Yolken, A. Alaedini, Novel immune response to gluten in individuals with schizophrenia, Schizophr Res. 118(2010) 248-255.
  38. S. Casella, B. Zanini, F. Lanzarotto, F. Caselani, A. Magni, G. Romanelli, A. Lanzini, Neuropsychological pattern during gluten-free diet (GFD) in elderly coeliacpatients,Gut.60 (2011) A86.

Source

Indexing and Abstracting

  • 1
  • 2
  • 3
  • 4
  • 5
Google Scholar Url for the Journal is not available